Table 4 Causes of death in both cohorts. Absolute numbers and percentages are given.

From: GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party

Causes

ATG, N = 1377

PTCY, N = 309

Categories, n(%)

 Original Disease

846 (62.9%)

171 (56.1%)

 Infection

184 (13.7%)

51 (16.7%)

 GVHD

150 (11.1%)

41 (13.4%)

 Other HSCT related

82 (6.1%)

23 (7.5%)

 Other

72 (5.4%)

13 (4.3%)

 Secondary malignancy

12 (0.9%)

6 (2%)

 Unknown

31

4